Florida

Miami, Florida 33144

0 studies enrolling now · 7 studies all time

What they study most

Hepatitis C, Partial Epilepsy, Skin Structures and Soft Tissue Infections

Studies at this site

• Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2 — Completed
• Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1 — Completed
• Telaprevir, Peg-IFN-alfa-2a, and RBV in Treatment-Experienced Black/African American and Non-Black/African American Subjects With Genotype 1 Chronic Hepatitis C — Stopped early
• An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients — Stopped early
• A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV) — Stopped early
• Virology Follow up Study in Subjects Previously Treated With Telaprevir — Completed
• Study of VX-765 in Subjects With Treatment-resistant Partial Epilepsy — Completed